- Home
- EXAS vs LPX Comparison
EXAS vs LPX Comparison
Compare EXAS & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- LPX
- Stock Information
- Founded
- EXAS 1995
- LPX 1973
- Country
- EXAS United States
- LPX United States
- Employees
- EXAS N/A
- LPX N/A
- Industry
- EXAS Medical Specialities
- LPX Forest Products
- Sector
- EXAS Health Care
- LPX Basic Materials
- Exchange
- EXAS Nasdaq
- LPX Nasdaq
- Market Cap
- EXAS 10.5B
- LPX 8.5B
- IPO Year
- EXAS N/A
- LPX N/A
- Fundamental
- Price
- EXAS $51.74
- LPX $114.92
- Analyst Decision
- EXAS Strong Buy
- LPX Hold
- Analyst Count
- EXAS 16
- LPX 10
- Target Price
- EXAS $72.80
- LPX $104.78
- AVG Volume (30 Days)
- EXAS 2.2M
- LPX 697.1K
- Earning Date
- EXAS 02-19-2025
- LPX 02-12-2025
- Dividend Yield
- EXAS N/A
- LPX 0.91%
- EPS Growth
- EXAS N/A
- LPX 276.87
- EPS
- EXAS N/A
- LPX 5.81
- Revenue
- EXAS $2,692,328,000.00
- LPX $2,919,000,000.00
- Revenue This Year
- EXAS $11.81
- LPX $14.06
- Revenue Next Year
- EXAS $11.52
- LPX $4.82
- P/E Ratio
- EXAS N/A
- LPX $19.78
- Revenue Growth
- EXAS 11.91
- LPX 11.07
- 52 Week Low
- EXAS $40.62
- LPX $63.76
- 52 Week High
- EXAS $79.62
- LPX $122.87
- Technical
- Relative Strength Index (RSI)
- EXAS 35.28
- LPX 61.12
- Support Level
- EXAS $49.79
- LPX $104.25
- Resistance Level
- EXAS $60.88
- LPX $113.88
- Average True Range (ATR)
- EXAS 2.67
- LPX 2.93
- MACD
- EXAS -0.59
- LPX 1.31
- Stochastic Oscillator
- EXAS 17.58
- LPX 78.58
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About LPX Louisiana-Pacific Corporation
Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.